129 results
Page 4 of 7
6-K
EX-99.1
23gtsjs94qj 006tu
19 Mar 19
RepliCel Reignites its First-in-Japan Strategy
12:11pm
6-K
EX-99.2
ap23k 19bek
26 Nov 18
Current report (foreign)
4:20pm
6-K
EX-99.2
p6bcct
30 May 18
Condensed Consolidated Interim Financial Statements
12:00am
20-F/A
eq0uq
12 Jan 18
Annual report (foreign) (amended)
12:00am
6-K
EX-99.1
hdswelqefxla4ml
25 Oct 17
Current report (foreign)
12:00am
6-K
EX-99.1
bs5d9u
20 Apr 16
RepliCel Life Sciences Finishes Enrolment for its Tendon Repair and Skin Rejuvenation Clinical Trials
12:00am
6-K
EX-99.1
rxwlnlp4dy52uua992d
20 Oct 15
First Participants Enrolled in RepliCel's Phase 1 Clinical Trial of its RCS-01 Dermatology Injectable
12:00am
6-K
EX-99.1
fx3687as mgf
23 Jul 15
RepliCel Receives Two Important Approvals for Dermal Rejuvenation Clinical Trial
12:00am
6-K
EX-99.1
mx9q2y54fyf
23 Feb 15
RepliCel Submits Clinical Trial Application for its Dermatological Product
12:00am
CORRESP
4ne65hhu5s6 tl
6 Jan 15
Correspondence with SEC
12:00am
6-K
EX-99.1
5vvh61 8kku
22 Dec 14
Current report (foreign)
12:00am
6-K
EX-99.1
zxavhbpul 86yx
1 Dec 14
RepliCel Life Sciences Receives Health Canada Clearance for Clinical Trial in Patients with Chronic Achilles Tendinosis
12:00am
6-K
EX-99.2
we57oxgih
26 Nov 14
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.1
45el68
29 Oct 14
RepliCel Submits Clinical Trial Application to Health Canada for its Chronic Achilles Tendinosis Trial
12:00am
6-K
EX-99.1
nvy30f1 1ib
3 Sep 14
RepliCel Life Sciences Joins Centre for Commercialization of Regenerative Medicine, Industry Consortium
12:00am